Terms: = Leukemia AND PIM1, PIM, 5292, ENSG00000137193, P11309 AND Diagnosis
12 results:
1. Corynoline inhibits esophageal squamous cell carcinoma growth via targeting pim-3.
Shi Y; Yuan Q; Chen Y; Li X; Zhou Y; Zhou H; Peng F; Jiang Y; Qiao Y; Zhao J; Zhang C; Wang J; Liu K; Dong Z
Phytomedicine; 2024 Jan; 123():155235. PubMed ID: 38128397
[TBL] [Abstract] [Full Text] [Related]
2. Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics Study.
Hekmatshoar Y; Rahbar Saadat Y; Ozkan T; Bozkurt S; Karadag Gurel A
Nucleosides Nucleotides Nucleic Acids; 2024; 43(7):664-684. PubMed ID: 38117080
[TBL] [Abstract] [Full Text] [Related]
3. Effects of pim3 in prognosis of colon cancer.
Zhou Y; Zhou YN; Liu SX; Wang J; Ji R; Yan X
Clin Transl Oncol; 2021 Oct; 23(10):2163-2170. PubMed ID: 33928496
[TBL] [Abstract] [Full Text] [Related]
4. Microenvironment-induced pim kinases promote CXCR4-triggered mTOR pathway required for chronic lymphocytic leukaemia cell migration.
Białopiotrowicz E; Górniak P; Noyszewska-Kania M; Puła B; Makuch-Łasica H; Nowak G; Bluszcz A; Szydłowski M; Jabłonska E; Piechna K; Sewastianik T; Polak A; Lech-Marańda E; Budziszewska BK; Wasylecka-Juszczyńska M; Borg K; Warzocha K; Czardybon W; Gałęzowski M; Windak R; Brzózka K; Juszczyński P
J Cell Mol Med; 2018 Jul; 22(7):3548-3559. PubMed ID: 29665227
[TBL] [Abstract] [Full Text] [Related]
5. pim Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer.
Aziz AUR; Farid S; Qin K; Wang H; Liu B
Biomolecules; 2018 Feb; 8(1):. PubMed ID: 29401696
[TBL] [Abstract] [Full Text] [Related]
6. Chronic Lymphocytic leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.
Xochelli A; Baliakas P; Kavakiotis I; Agathangelidis A; Sutton LA; Minga E; Ntoufa S; Tausch E; Yan XJ; Shanafelt T; Plevova K; Boudjogra M; Rossi D; Davis Z; Navarro A; Sandberg Y; Vojdeman FJ; Scarfo L; Stavroyianni N; Sudarikov A; Veronese S; Tzenou T; Karan-Djurasevic T; Catherwood M; Kienle D; Chatzouli M; Facco M; Bahlo J; Pott C; Pedersen LB; Mansouri L; Smedby KE; Chu CC; Giudicelli V; Lefranc MP; Panagiotidis P; Juliusson G; Anagnostopoulos A; Vlahavas I; Antic D; Trentin L; Montillo M; Niemann C; Döhner H; Langerak AW; Pospisilova S; Hallek M; Campo E; Chiorazzi N; Maglaveras N; Oscier D; Gaidano G; Jelinek DF; Stilgenbauer S; Chouvarda I; Darzentas N; Belessi C; Davi F; Hadzidimitriou A; Rosenquist R; Ghia P; Stamatopoulos K
Clin Cancer Res; 2017 Sep; 23(17):5292-5301. PubMed ID: 28536306
[No Abstract] [Full Text] [Related]
7. The evolving landscape in the therapy of acute myeloid leukemia.
Peloquin GL; Chen YB; Fathi AT
Protein Cell; 2013 Oct; 4(10):735-46. PubMed ID: 23982740
[TBL] [Abstract] [Full Text] [Related]
8. Calix[6]arene bypasses human pancreatic cancer aggressiveness: downregulation of receptor tyrosine kinases and induction of cell death by reticulum stress and autophagy.
Pelizzaro-Rocha KJ; de Jesus MB; Ruela-de-Sousa RR; Nakamura CV; Reis FS; de Fátima A; Ferreira-Halder CV
Biochim Biophys Acta; 2013 Dec; 1833(12):2856-2865. PubMed ID: 23872419
[TBL] [Abstract] [Full Text] [Related]
9. Expression of pim-2 and NF-κB genes is increased in patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) and is associated with complete remission rate and overall survival.
Kapelko-Słowik K; Urbaniak-Kujda D; Wołowiec D; Jaźwiec B; Dybko J; Jakubaszko J; Słowik M; Kuliczkowski K
Postepy Hig Med Dosw (Online); 2013 Jun; 67():553-9. PubMed ID: 23752607
[TBL] [Abstract] [Full Text] [Related]
10. [Acute monocytic leukemia after orthotopic liver transplantation: clinical features, molecular genetics, and significance thereof].
Zhang GS; Peng HL; Dai CW; Gong FJ; Xu YX; Xiao L; Pei MF; Shen JK; Yang JJ
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3504-8. PubMed ID: 16686070
[TBL] [Abstract] [Full Text] [Related]
11. Long term follow-up of Asian patients with chronic myeloid leukemia (CML) receiving allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-identical sibling-evaluation of risks and benefits.
Koh LP; Hwang WY; Tan CH; Linn YC; Goh YT; Chuah CT; Ng HJ; Fook-Chong SM; Tan PH
Ann Hematol; 2004 May; 83(5):286-94. PubMed ID: 15060748
[TBL] [Abstract] [Full Text] [Related]
12. Potential cellular signatures of viral infections in human hematopoietic cells.
Mikovits J; Ruscetti F; Zhu W; Bagni R; Dorjsuren D; Shoemaker R
Dis Markers; 2001; 17(3):173-8. PubMed ID: 11790884
[TBL] [Abstract] [Full Text] [Related]